Affiliation:
1. Institute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition University of Aberdeen Aberdeen UK
2. Department of Neurology Columbia University New York NY USA
3. Department of Biosciences Durham University Durham UK
4. Eli Lilly Bracknell UK
5. CNRS UMR 5297, Interdisciplinary Institute of Neuroscience University of Bordeaux Bordeaux France
Abstract
AbstractA metabotropic glutamate receptor coupled to phospholipase D (PLD‐mGluR) was discovered in the hippocampus over three decades ago. Its pharmacology and direct linkage to PLD activation are well established and indicate it is a highly atypical glutamate receptor. A receptor with the same pharmacology is present in spindle primary sensory terminals where its blockade can totally abolish, and its activation can double, the normal stretch‐evoked firing. We report here the first identification of this PLD‐mGluR protein, by capitalizing on its expression in primary mechanosensory terminals, developing an enriched source, pharmacological profiling to identify an optimal ligand, and then functionalizing it as a molecular tool. Evidence from immunofluorescence, western and far‐western blotting indicates PLD‐mGluR is homomeric GluK2, since GluK2 is the only glutamate receptor protein/receptor subunit present in spindle mechanosensory terminals. Its expression was also found in the lanceolate palisade ending of hair follicle, also known to contain the PLD‐mGluR. Finally, in a mouse model with ionotropic function ablated in the GluK2 subunit, spindle glutamatergic responses were still present, confirming it acts purely metabotropically. We conclude the PLD‐mGluR is a homomeric GluK2 kainate receptor signalling purely metabotropically and it is common to other, perhaps all, primary mechanosensory endings.
Subject
Physiology,Physiology (medical),Nutrition and Dietetics,Physiology,Physiology (medical),Nutrition and Dietetics